IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+29.45%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$368M
AUM Growth
+$368M
Cap. Flow
-$72.5M
Cap. Flow %
-19.73%
Top 10 Hldgs %
47.34%
Holding
127
New
24
Increased
22
Reduced
26
Closed
20

Top Buys

1
CRBP icon
Corbus Pharmaceuticals
CRBP
$14.3M
2
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$10.9M
3
CYTK icon
Cytokinetics
CYTK
$8.07M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$7.7M
5
PYXS icon
Pyxis Oncology
PYXS
$7.08M

Top Sells

1
ARGX icon
argenx
ARGX
$26.5M
2
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$21.2M
3
XHB icon
SPDR S&P Homebuilders ETF
XHB
$19.1M
4
NUVL icon
Nuvalent
NUVL
$11.8M
5
IRON icon
Disc Medicine
IRON
$10.6M

Sector Composition

1 Healthcare 98.68%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LNTH icon
101
Lantheus
LNTH
$3.75B
– –
-15,000
Closed -$930K
LLY icon
102
Eli Lilly
LLY
$661B
– –
0
– –
KRYS icon
103
Krystal Biotech
KRYS
$4.35B
– –
0
– –
JAZZ icon
104
Jazz Pharmaceuticals
JAZZ
$7.99B
– –
0
– –
GPCR icon
105
Structure Therapeutics
GPCR
$1.14B
– –
-14,524
Closed -$592K
CBIO
106
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
– –
0
– –
FDMT icon
107
4D Molecular Therapeutics
FDMT
$302M
– –
0
– –
ESPR icon
108
Esperion Therapeutics
ESPR
$490M
– –
-337,636
Closed -$1.01M
DYN icon
109
Dyne Therapeutics
DYN
$1.92B
– –
-285,900
Closed -$3.8M
CRSP icon
110
CRISPR Therapeutics
CRSP
$4.82B
– –
-70,546
Closed -$4.42M
CORT icon
111
Corcept Therapeutics
CORT
$7.52B
– –
0
– –
CLDX icon
112
Celldex Therapeutics
CLDX
$1.57B
– –
0
– –
CHRS icon
113
Coherus Oncology, Inc. Common Stock
CHRS
$146M
– –
-340,787
Closed -$1.13M
CABA icon
114
Cabaletta Bio
CABA
$144M
– –
-216,620
Closed -$4.92M
BMEA icon
115
Biomea Fusion
BMEA
$114M
– –
0
– –
BHVN icon
116
Biohaven
BHVN
$1.71B
– –
0
– –
BDTX icon
117
Black Diamond Therapeutics
BDTX
$164M
– –
-555,572
Closed -$1.56M
AZN icon
118
AstraZeneca
AZN
$255B
– –
0
– –
AUTL
119
Autolus Therapeutics
AUTL
$383M
– –
-262,694
Closed -$1.69M
ARGX icon
120
argenx
ARGX
$44.2B
– –
-70,000
Closed -$26.5M
ARE icon
121
Alexandria Real Estate Equities
ARE
$13.9B
– –
0
– –
ANVS icon
122
Annovis Bio
ANVS
$44.4M
– –
0
– –
AMGN icon
123
Amgen
AMGN
$153B
– –
0
– –
MDGL icon
124
Madrigal Pharmaceuticals
MDGL
$9.7B
– –
0
– –
EWTX icon
125
Edgewise Therapeutics
EWTX
$1.54B
– –
-270,000
Closed -$2.95M
2 3 4
5
6